The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 253.50
Bid: 250.50
Ask: 251.50
Change: 2.50 (1.00%)
Spread: 1.00 (0.399%)
Open: 246.50
High: 253.50
Low: 246.50
Prev. Close: 251.00
CSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on AGM Voting

15 Nov 2023 07:00

RNS Number : 4553T
Chesnara PLC
15 November 2023
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

15th November 2023

 

CHESNARA plc

("Chesnara", the "Company" or the "Group")

 

RESPONSE TO VOTING RESULTS AT 2023 ANNUAL GENERAL MEETING

 

In accordance with Provision-4 of the UK Corporate Governance Code, Chesnara (CSN.L), the European life insurance consolidator, today provides an update to our statement of 16th May 2023 regarding the result of the poll vote at the 2023 Annual General Meeting ("AGM") on Resolution-2 to approve the Directors' Remuneration Report.

 

Resolution-2 passed with 72.66% of votes in favour. Since the AGM, the Remuneration Committee has engaged with the Company's major shareholders and proxy agencies to help understand the reasons for votes cast against Resolution-2. Three areas have been identified, which are in line with those raised by proxy investor bodies in their respective reports published just in advance of the 2023 AGM. We set them out below, alongside the proposed response to each.

 

 

LTIP to be Based One Third on Surplus Emergence

 

One area of feedback related to the use of cash generation metrics in both the Short Term Incentive Scheme ("STIS") and Long Term Incentive Plan ("LTIP"). In response to this, for LTIP awards granted in FY24, the Commercial Cash Generation metric will be replaced by a new Surplus Emergence metric. The existing relative TSR and Economic Value growth metrics will be retained. Each metric will be weighted one third of the assessment in line with the current approach.

 

Surplus Emergence will be one of the Group's KPIs and will be consistent with the definition used for reporting elsewhere in the annual report and the Company's other trading updates. It represents the operational surplus that has been generated in the period, largely a function of the movement in the solvency position of the insurance subsidiaries within the Group and takes account of the buffers that management has set to hold over and above the solvency requirements imposed locally by our regulators.

 

 

All LTIP Performance Targets to be Disclosed Prospectively

 

Shareholders expressed a preference for LTIP performance targets to be disclosed prospectively, in line with the approach the Company has always taken for the relative TSR metric. The Company acknowledges that this is increasingly common practice and going forward will disclose threshold targets prospectively going forwards, commencing with the targets for the LTIP awards to be granted in 2024.

 

 

Assessment of the Company's M&A Activity Within the Strategic Scorecard of the STIS

 

For 2024, the Remuneration Committee is proposing to make a small modification to the performance measures to be included in the STIS. The Strategic Scorecard (30% weighting) will be replaced by an ESG metric (5% weighting) and a Strategic Activity Scorecard (25% weighting) which focuses on the assessment of value-enhancing strategic activities including M&A, management actions, operational programme delivery and pipeline development. The weightings within the Strategic Activity Scorecard will vary year-to-year to reflect the relative priorities for the Company.

 

This means the assessment of M&A activity for the FY24 STIS will be entirely contained within the Strategic Activity Scorecard with no discretion applied. Full details of the assessment of the Strategic Activity Scorecard will be included in the Directors' Remuneration Report each year.

 

 

 

 

 

The Remuneration Committee would like to thank the major shareholders who have engaged in the consultation exercise since the AGM and believes that the proposed changes address the key issues raised. In accordance with the Corporate Governance Code, a final summary will be provided in the Company's 2023 Annual Report.

 

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured and CASLP in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 18 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMNKQBDFBDDODD
Date   Source Headline
1st Feb 201211:43 amRNSHolding(s) in Company
16th Jan 20124:21 pmRNSHolding(s) in Company
15th Dec 201112:11 pmRNSSave & Prosper Part VII Transfer Approved
12th Dec 20113:18 pmRNSHolding(s) in Company
18th Nov 20117:00 amRNSInterim Management Statement
20th Oct 20115:45 pmPRNAnnouncement Released in Error
14th Oct 201110:06 amRNSHolding(s) in Company
6th Oct 20114:35 pmRNSPrice Monitoring Extension
31st Aug 20117:00 amPRNHalf-yearly Report
1st Aug 20113:23 pmPRNNotice of Interim Results
19th May 20117:00 amPRN1st Quarter Results
19th May 20117:00 amPRN1st Quarter Results
17th May 201111:57 amPRNResult of AGM
13th Apr 20114:42 pmPRNAnnual Financial Report
1st Apr 20119:20 amPRNAnnual Information Update
31st Mar 20117:00 amPRNFinal Results
4th Mar 20113:21 pmPRNNotice of Results
2nd Feb 20114:17 pmPRNHolding(s) in Company
20th Dec 20102:50 pmPRNAcquisition(s)
17th Dec 20104:40 pmRNSSecond Price Monitoring Extn
17th Dec 20104:35 pmRNSPrice Monitoring Extension
16th Dec 201012:16 pmPRNResult of GM
7th Dec 20108:54 amPRNHolding(s) in Company
6th Dec 20103:19 pmPRNHolding(s) in Company
1st Dec 20102:58 pmPRNHolding(s) in Company
1st Dec 20102:23 pmPRNTotal Voting Rights
30th Nov 20105:06 pmPRNStatement re : Posting of Circular to Shareholders
26th Nov 20101:42 pmRNSResult of placing
26th Nov 20109:29 amPRNAcquisition(s)
19th Nov 20107:00 amPRNInterim Management Statement
28th Sep 20109:16 amPRNHolding(s) in Company
26th Aug 20107:00 amPRNHalf-yearly Report
11th Aug 20109:31 amPRNNotice of Results
18th Jun 20104:35 pmRNSPrice Monitoring Extension
19th May 20107:00 amPRNInterim Management Statement
13th May 20101:55 pmPRNResult of AGM
27th Apr 20102:29 pmPRNAnnual Financial Report
1st Apr 201010:11 amPRNAnnual Information Update
31st Mar 20107:00 amPRNFinal Results
8th Mar 20109:20 amPRNNotice of Results
14th Dec 20093:41 pmPRNHolding(s) in Company
11th Dec 20099:52 amPRNAcquisition(s)
3rd Dec 200910:14 amPRNHolding(s) in Company
30th Nov 20091:43 pmPRNHolding(s) in Company
27th Nov 20091:20 pmPRNHolding(s) in Company
19th Nov 20097:00 amPRNInterim Management Statement
10th Nov 20094:07 pmPRNHolding(s) in Company
3rd Nov 20097:00 amPRNAppointment of Joint Corporate Broker
27th Oct 20092:26 pmPRNTrading Update
9th Oct 200910:37 amPRNCircular regarding the change of auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.